[topsearch__bar__shortcode]

January 22, 2025

Last Week’s Rally Eases As BTCS Stock Levels Out

Following a robust weekly gain exceeding 25%, BTCS Inc. (NASDAQ: BTCS) experienced a correction phase, with shares declining by 4.48% to close the previous session at $3.41. The surge began with a 33.21% jump last Friday, pushing the stock to $3.57, driven by the announcement of a new growth strategy. The company also holds a […]

Last Week’s Rally Eases As BTCS Stock Levels Out Read More »

Nukkleus (NUKK) Stock Surges Amid Defense Sector Optimism

Nukkleus Inc. (NASDAQ: NUKK) experienced a sharp increase in its stock price on Tuesday, indicating that the company is making headway in obtaining a piece of a multibillion-dollar defense industry opportunity. During the regular trading session, the company’s shares increased 8.00% to $31.86 further elevating from the previous-day rise of 43.69% to close at $29.50.

Nukkleus (NUKK) Stock Surges Amid Defense Sector Optimism Read More »

Alpha Modus (AMOD) Stock Eases Following A Short-Lived Rally

Over the course of the last trading session, Alpha Modus Holdings, Inc. (NASDAQ: AMOD) stock performance saw a notable correction, finishing at %1.96, down -14.97%. That followed a previous-day rise of more than 30$ closing at $2.30 on Monday. Although no specific news was linked to this price fluctuation, recent strategic developments may have fueled

Alpha Modus (AMOD) Stock Eases Following A Short-Lived Rally Read More »

INNOVATE (VATE) Stock Soars As Market Reacts To Regulatory Achievement

During the previous session, INNOVATE Corp. (NYSE: VATE) rose to $9.52, a significant increase of 86.30%. This rise in VATE stock price was caused by the announcement that the U.S. Food and Drug Administration (FDA) has authorized INNOVATE’s novel MediBeacon Transdermal Glomerular Filtration Rate (TGFR) System. The FDA Approves the Innovative Kidney Function System The

INNOVATE (VATE) Stock Soars As Market Reacts To Regulatory Achievement Read More »